Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Janet E Pope

Showing results (31-40 of 299) with videos related to

Pageof 30
Sort By:
Medical Science Monitor : International Medical Journal of Experimental and Clinical Research|August 31, 2010
The efficacy of treatment for systemic sclerosis interstitial lung disease: results from a meta-analysisKathleen Broad, Janet E Pope
Clinical and Experimental Rheumatology|May 31, 2018
Appropriate cardiovascular disease risk assessment in systemic lupus erythematosus may be lacking in rheumatology practiceFaranak Esmaeilbeigi, Janet E Pope
RMD Open|March 14, 2018
Physician global assessments for disease activity in rheumatoid arthritis are all over the map!Matthew Turk, Janet E Pope
The Journal of Rheumatology|May 3, 2016
The Frequency of Scleroderma Renal Crisis over Time: A MetaanalysisMatthew Turk, Janet E Pope
Clinical and Experimental Rheumatology|August 6, 2013
The significance of interleukin-6 and C-reactive protein in systemic sclerosis: a systematic literature reviewChayawee Muangchant, Janet E Pope
Arthritis Care & Research|March 2, 2019
Is It Time to Banish Composite Measures for Remission in Rheumatoid Arthritis?Janet E Pope, Kaleb Michaud
The Journal of Rheumatology|February 9, 2002
Alkaptonuria with atypical joint involvementAli Alrehaily, Janet E Pope
The Journal of Rheumatology|February 12, 2009
Squamous cell carcinomas in 2 patients with diffuse scleroderma treated with mycophenolate mofetilAliya Gulamhusein, Janet E Pope
Arthritis Care & Research|January 28, 2016
ReplyChayawee Muangchan, Janet E Pope
Autoimmunity Reviews|September 17, 2020
Undifferentiated connective tissue disease at risk for systemic sclerosis: Which patients might be labeled prescleroderma?Gabriele Valentini, Janet E Pope
Pageof 30

Showing results (31-40 of 299) with videos related to

Sort By:
Pageof 30
Medical Science Monitor : International Medical Journal of Experimental and Clinical Research|August 31, 2010
The efficacy of treatment for systemic sclerosis interstitial lung disease: results from a meta-analysisKathleen Broad, Janet E Pope
Clinical and Experimental Rheumatology|May 31, 2018
Appropriate cardiovascular disease risk assessment in systemic lupus erythematosus may be lacking in rheumatology practiceFaranak Esmaeilbeigi, Janet E Pope
RMD Open|March 14, 2018
Physician global assessments for disease activity in rheumatoid arthritis are all over the map!Matthew Turk, Janet E Pope
The Journal of Rheumatology|May 3, 2016
The Frequency of Scleroderma Renal Crisis over Time: A MetaanalysisMatthew Turk, Janet E Pope
Clinical and Experimental Rheumatology|August 6, 2013
The significance of interleukin-6 and C-reactive protein in systemic sclerosis: a systematic literature reviewChayawee Muangchant, Janet E Pope
Arthritis Care & Research|March 2, 2019
Is It Time to Banish Composite Measures for Remission in Rheumatoid Arthritis?Janet E Pope, Kaleb Michaud
The Journal of Rheumatology|February 9, 2002
Alkaptonuria with atypical joint involvementAli Alrehaily, Janet E Pope
The Journal of Rheumatology|February 12, 2009
Squamous cell carcinomas in 2 patients with diffuse scleroderma treated with mycophenolate mofetilAliya Gulamhusein, Janet E Pope
Arthritis Care & Research|January 28, 2016
ReplyChayawee Muangchan, Janet E Pope
Autoimmunity Reviews|September 17, 2020
Undifferentiated connective tissue disease at risk for systemic sclerosis: Which patients might be labeled prescleroderma?Gabriele Valentini, Janet E Pope
Pageof 30